ascopubs.org

Development and validation of an AI-enabled prediction of prostate cancer (PCa) using urine ...

A phase 1 study of PARP inhibitor (niraparib) plus HSP90 inhibitor (pimitespib) in solid tumors: Dose-expansion results from the NiraPim (EPOC2102) study. Genomic landscape of 5’methylthioadenosine ...